Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on July 22, 2026

Jul. 22, 2026

Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026

Indeterminate GlobeNewswire

Jul. 22, 2026

Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease

Indeterminate GlobeNewswire

Jul. 22, 2026

VisiRose Selected to Present RB-PDAT at ESCRS iNovation® Day 2026 Emerging Company Showcase

Indeterminate GlobeNewswire

Jul. 22, 2026

KC BioHub Awarded $38.1 Million to Advance Regional Biomanufacturing Growth

Indeterminate GlobeNewswire

Jul. 22, 2026

Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors 

Indeterminate GlobeNewswire

Jul. 22, 2026

LB Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 NOVA-2 Trial of LB-102 in Schizophrenia

Indeterminate GlobeNewswire

Jul. 22, 2026

Unnatural Products Appoints Finance Leader Neera Ravindran, M.D., M.B.A., as Chief Financial Officer

Indeterminate GlobeNewswire

Jul. 22, 2026

Canadian Pet Parents Continue to Prioritize Pet Spending over their Everyday Pleasures

Indeterminate GlobeNewswire

Jul. 22, 2026

Zevra Therapeutics Announces Details for Q2 2026 Financial Results Call

Indeterminate GlobeNewswire

Jul. 22, 2026

BridgeBio Announces FDA Acceptance of NDA for Encaleret for ADH1

Indeterminate GlobeNewswire

Jul. 22, 2026

Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology

Indeterminate GlobeNewswire

Jul. 22, 2026

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

Indeterminate GlobeNewswire

Jul. 22, 2026

Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy

Indeterminate GlobeNewswire

Jul. 22, 2026

uniQure to Announce Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 22, 2026

Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune

Indeterminate GlobeNewswire

Jul. 22, 2026

Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases

Indeterminate GlobeNewswire

Jul. 22, 2026

Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026

Indeterminate GlobeNewswire

Jul. 22, 2026

Avalo Therapeutics to Participate in the BTIG Biotechnology Conference

Indeterminate GlobeNewswire

Jul. 22, 2026

Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026

Indeterminate GlobeNewswire

Jul. 22, 2026

BioCryst to Report Second Quarter 2026 Financial Results on August 5

Indeterminate GlobeNewswire